0 Speaker List

News

Dr. Scott Gottlieb says Hillary Clinton’s plan to lower drug costs is ‘misdirected’

(Original source Becker’s Hospital Review)

“Democratic presidential candidate Hillary Clinton’s plan to focus on the “price gouging” by pharmaceutical companies and the need for price regulation will only lead the industry further astray, according to Scott Gottlieb’s, MD, recent article in The Wall Street Journal.

“What [Ms. Clinton] fails to comprehend is that the high drug prices she decries aren’t the result of market forces gone wild. Rather, they are the result of bad regulation that has created market failures and shortages,” Dr. Gottlieb, a physician and resident fellow at the American Enterprise Institute, wrote in the WSJ.”

Click here to read more

Get A Quote For: